Sato Masakazu

Affiliation and department：

Research field (1)： Obstetrics and gynecology

Research theme for competitive and other funds (3)：

2019 - 2021 Study of the Clinical Significance of Metabolism-related Genes in Ovarian High-grade Serous Carcinoma
2016 - 2019 Cervical cancer stem cell model derived from iPS cells to investigate new therapeutic targets
2016 - 2018 The study about omega-3 fatty acids and their metabolites as preventive drugs for premature birth

Papers (29)：

Masakazu Sato, Sho Sato, Daisuke Shintani, Mieko Hanaoka, Aiko Ogasawara, Maiko Miwa, Akira Yabuno, Akira Kurosaki, Hiroyuki Yoshida, Keiichi Fujiwara, et al. Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma. BMC cancer. 2022. 22. 1. 59-59
Masakazu Sato, Daisuke Shintani, Mieko Hanaoka, Sho Sato, Maiko Miwa, Aiko Ogasawara, Akira Yabuno, Akira Kurosaki, Hiroyuki Yoshida, Keiichi Fujiwara, et al. A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm. Molecular and clinical oncology. 2021. 15. 4. 207-207
Machiko Kojima, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Shinya Oki, Asako Kukita, Akira Kawata, Harunori Honjoh, Yoshiko Kawata, et al. The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells. Oncology letters. 2020. 20. 5. 153-153
Masakazu Sato, Minako Koizumi, Minoru Nakabayashi, Kei Inaba, Yu Takahashi, Natsuki Nagashima, Hiroshi Ki, Nao Itaoka, Chiharu Ueshima, Maki Nakata, et al. Computer vision for total laparoscopic hysterectomy. Asian journal of endoscopic surgery. 2019. 12. 3. 294-300
Asako Kukita, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu, Miku Wada, Harunori Honjoh, Yoshiko Kawata, Machiko Kojima, et al. Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas. Biochemical and biophysical research communications. 2019. 513. 2. 340-346

ｍore...

MISC (63)：

佐藤雅和. 今日の話題医師業務負担軽減のための診療科データベースの構築. 産婦人科の実際. 2023. 72. 4. 423-429
鈴木由梨奈, 堀江弘二, 稲葉洋文, 神田蘭香, 佐藤雅和, 天神林友梨, 廣瀬佑輔, 宮坂亞希, 横田治重. オラパリブ維持療法後のプラチナ製剤再投与の効果についての検討. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 204-204
天神林友梨, 稲葉洋文, 神田蘭香, 佐藤雅和, 廣瀬佑輔, 鈴木由梨奈, 宮坂亞希, 堀江弘二, 横田治重. 子宮内膜症に由来した卵巣発生の低悪性度内膜間質肉腫の一例. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 284-284
廣瀬佑輔, 稲葉洋文, 神田蘭香, 佐藤雅和, 天神林友梨, 鈴木由梨奈, 宮坂亞希, 堀江弘二. 当院での初回卵巣癌維持療法におけるニラパリブの使用実績. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 286-286
佐藤雅和, 堀江弘二, 稲葉洋文, 神田蘭香, 廣瀬佑輔, 天神林友梨, 鈴木由梨奈, 宮坂亞希, 横田治重. Precision Medicine時代における診療科データベースの入力支援システムの構築. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 301-301

ｍore...

Education (1)：

2014 - 2018 The University of Tokyo Graduate School of Medicine Department of Obstetrics and Gynecology

Professional career (1)：

医学博士 (東京大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page